Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2009 Sep 15;10637:15927-31. doi: 10.1073/pnas.0907324106.
Show Gene links
Show Anatomy links
Blockage of A2A and A3 adenosine receptors decreases the desensitization of human GABA(A) receptors microtransplanted to Xenopus oocytes.
Roseti C
,
Palma E
,
Martinello K
,
Fucile S
,
Morace R
,
Esposito V
,
Cantore G
,
Arcella A
,
Giangaspero F
,
Aronica E
,
Mascia A
,
Di Gennaro G
,
Quarato PP
,
Manfredi M
,
Cristalli G
,
Lambertucci C
,
Marucci G
,
Volpini R
,
Limatola C
,
Eusebi F
.
???displayArticle.abstract???
We previously found that the endogenous anticonvulsant adenosine, acting through A(2A) and A(3) adenosine receptors (ARs), alters the stability of currents (I(GABA)) generated by GABA(A) receptors expressed in the epileptic human mesial temporal lobe (MTLE). Here we examined whether ARs alter the stability (desensitization) of I(GABA) expressed in focal cortical dysplasia (FCD) and in periglioma epileptic tissues. The experiments were performed with tissues from 23 patients, using voltage-clamp recordings in Xenopus oocytes microinjected with membranes isolated from human MTLE and FCD tissues or using patch-clamp recordings of pyramidal neurons in epileptic tissue slices. On repetitive activation, the epileptic GABA(A) receptors revealed instability, manifested by a large I(GABA) rundown, which in most of the oocytes (approximately 70%) was obviously impaired by the new A(2A) antagonists ANR82, ANR94, and ANR152. In most MTLE tissue-microtransplanted oocytes, a new A(3) receptor antagonist (ANR235) significantly improved I(GABA) stability. Moreover, patch-clamped pyramidal neurons from human neocortical slices of periglioma epileptic tissues exhibited altered I(GABA) rundown on ANR94 treatment. Our findings indicate that antagonizing A(2A) and A(3) receptors increases the I(GABA) stability in different epileptic tissues and suggest that adenosine derivatives may offer therapeutic opportunities in various forms of human epilepsy.
Bahima,
Endogenous hemichannels play a role in the release of ATP from Xenopus oocytes.
2006, Pubmed,
Xenbase
Bahima,
Endogenous hemichannels play a role in the release of ATP from Xenopus oocytes.
2006,
Pubmed
,
Xenbase
Bell-Horner,
ERK/MAPK pathway regulates GABAA receptors.
2006,
Pubmed
Boison,
Adenosine as a neuromodulator in neurological diseases.
2008,
Pubmed
Boison,
The adenosine kinase hypothesis of epileptogenesis.
2008,
Pubmed
Cepeda,
Immature neurons and GABA networks may contribute to epileptogenesis in pediatric cortical dysplasia.
2007,
Pubmed
Cherubini,
GABA: an excitatory transmitter in early postnatal life.
1991,
Pubmed
Ciruela,
Heterodimeric adenosine receptors: a device to regulate neurotransmitter release.
2006,
Pubmed
Fredholm,
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.
2001,
Pubmed
Fredholm,
Adenosine, an endogenous distress signal, modulates tissue damage and repair.
2007,
Pubmed
Goodkin,
GABA(A) receptor internalization during seizures.
2007,
Pubmed
Gourine,
Release of ATP in the central nervous system during systemic inflammation: real-time measurement in the hypothalamus of conscious rabbits.
2007,
Pubmed
Jacobson,
Adenosine receptors as therapeutic targets.
2006,
Pubmed
Klotz,
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
1998,
Pubmed
Kobayashi,
Functional characterization of an endogenous Xenopus oocyte adenosine receptor.
2002,
Pubmed
,
Xenbase
Lambertucci,
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
2009,
Pubmed
McDonald,
Adjacent phosphorylation sites on GABAA receptor beta subunits determine regulation by cAMP-dependent protein kinase.
1998,
Pubmed
McGaraughty,
Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors.
2005,
Pubmed
Melani,
Adenosine extracellular levels in human brain gliomas: an intraoperative microdialysis study.
2003,
Pubmed
Miledi,
A calcium-dependent transient outward current in Xenopus laevis oocytes.
1982,
Pubmed
,
Xenbase
Miledi,
Microtransplantation of neurotransmitter receptors from cells to Xenopus oocyte membranes: new procedure for ion channel studies.
2006,
Pubmed
,
Xenbase
Pagonopoulou,
Modulatory role of adenosine and its receptors in epilepsy: possible therapeutic approaches.
2006,
Pubmed
Palma,
Phosphatase inhibitors remove the run-down of gamma-aminobutyric acid type A receptors in the human epileptic brain.
2004,
Pubmed
,
Xenbase
Palma,
BDNF modulates GABAA receptors microtransplanted from the human epileptic brain to Xenopus oocytes.
2005,
Pubmed
,
Xenbase
Palma,
GABA(A)-current rundown of temporal lobe epilepsy is associated with repetitive activation of GABA(A) "phasic" receptors.
2007,
Pubmed
,
Xenbase
Palmini,
Terminology and classification of the cortical dysplasias.
2004,
Pubmed
Ragozzino,
Rundown of GABA type A receptors is a dysfunction associated with human drug-resistant mesial temporal lobe epilepsy.
2005,
Pubmed
,
Xenbase
Ribeiro,
Adenosine receptors in the nervous system: pathophysiological implications.
2002,
Pubmed
Roseti,
Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors.
2008,
Pubmed
,
Xenbase
Song,
Protein kinase C regulation of GABAA receptors.
2005,
Pubmed
Volpini,
Adenosine A2A receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease.
2009,
Pubmed
